HBM Healthcare Investments Aktie

HBM Healthcare Investments für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 984345 / ISIN: CH0012627250

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
01.10.2025 17:49:15

HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4 per cent in the second quarter of the 2025/2026 financial year

HBM Healthcare Investments AG / Key word(s): Half Year Results
HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4 per cent in the second quarter of the 2025/2026 financial year

01-Oct-2025 / 17:49 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


HBM Healthcare Investments delivered a convincing performance in the second quarter of the 2025/2026 financial year, increasing its net asset value (NAV) per share by 16.4 per cent to CHF 251.78.  This resulted in a quarterly profit of CHF 236 million, more than offsetting the primarily currency-related loss from the first quarter.

For the first half of the current financial year, the company expects a profit of CHF 96 million with a 6.1 percent increase in NAV in Swiss francs (17.8 percent in US Dollars). The share price rose by 4.0 percent over the same period, but continues to trade at a significant discount of 28 percent to net asset value.

The positive performance in the second quarter is primarily attributable to renewed momentum among the listed portfolio companies. Significant impetus came from positive clinical trial results from Abivax, Mineralys, Upstream Bio, and UniQure, as well as takeover bids for Merus, Y-mAbs Therapeutics, and 89Bio. Foreign currencies had no significant impact on second-quarter performance.

HBM Healthcare Investments remains confident about the second half of the financial year and expects further positive momentum from its investments in private and listed companies.

The figures quoted are preliminary results based on the current status of the financial statements. The final half-year results will be published on 24 October 2025.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of Inside Information
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 2207074

 
End of Announcement EQS News Service

2207074  01-Oct-2025 CET/CEST

Analysen zu HBM Healthcare Investments AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

HBM Healthcare Investments AG 197,40 2,28% HBM Healthcare Investments AG